Cargando…

Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery

PURPOSE: To analyze and report the long-term outcomes of intracranial arteriovenous malformations (AVM) treated with linear accelerator (LINAC)-based radiosurgery (LBRS) in the pediatric population. METHODS AND MATERIALS: A series of 34 pediatric patients (≤18 years old) who were treated between 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Glazener, Ethan M., Lodin, Kenneth, Miller, Michael J., Frager, Matthew J., Rahimian, Javad, Chen, Joseph C.T., Girvigian, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560570/
https://www.ncbi.nlm.nih.gov/pubmed/33089017
http://dx.doi.org/10.1016/j.adro.2020.03.018
_version_ 1783595113854795776
author Glazener, Ethan M.
Lodin, Kenneth
Miller, Michael J.
Frager, Matthew J.
Rahimian, Javad
Chen, Joseph C.T.
Girvigian, Michael R.
author_facet Glazener, Ethan M.
Lodin, Kenneth
Miller, Michael J.
Frager, Matthew J.
Rahimian, Javad
Chen, Joseph C.T.
Girvigian, Michael R.
author_sort Glazener, Ethan M.
collection PubMed
description PURPOSE: To analyze and report the long-term outcomes of intracranial arteriovenous malformations (AVM) treated with linear accelerator (LINAC)-based radiosurgery (LBRS) in the pediatric population. METHODS AND MATERIALS: A series of 34 pediatric patients (≤18 years old) who were treated between 2002 and 2016 were analyzed. All patients were treated with LBRS in a single fraction, with a median dose of 16.8 Gy to the 80% isodose line. Median age at treatment was 14.4 years (range 5.5-18.9). Median AVM volume was 2.91 mL (range 0.228-27.313). Median modified radiosurgery-based AVM score was 0.83 (range 0.18-2.96). The most common presenting symptom was intracranial hemorrhage (ICH) (n = 22, 64.7%). Nine patients underwent intervention before LBRS, which included prior embolization or resection. Seven lesions were in eloquent locations, defined as basal ganglia, thalamus, or brainstem. Cerebral angiography was done to confirm obliteration. RESULTS: Median follow-up time was 98 months (range 36-200 months). Twenty-two of the 34 lesions were obliterated (64.7%) with median time to obliteration of 37 months (range 14-79). No deaths occurred during the follow up period; however, two patients experienced ICH after treatment. Three other patients were treated for symptomatic radiation necrosis. CONCLUSIONS: Treatment of intracranial AVM with LBRS in the pediatric population is demonstrated to be safe and effective with long-term follow up.
format Online
Article
Text
id pubmed-7560570
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75605702020-10-20 Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery Glazener, Ethan M. Lodin, Kenneth Miller, Michael J. Frager, Matthew J. Rahimian, Javad Chen, Joseph C.T. Girvigian, Michael R. Adv Radiat Oncol Scientific Article PURPOSE: To analyze and report the long-term outcomes of intracranial arteriovenous malformations (AVM) treated with linear accelerator (LINAC)-based radiosurgery (LBRS) in the pediatric population. METHODS AND MATERIALS: A series of 34 pediatric patients (≤18 years old) who were treated between 2002 and 2016 were analyzed. All patients were treated with LBRS in a single fraction, with a median dose of 16.8 Gy to the 80% isodose line. Median age at treatment was 14.4 years (range 5.5-18.9). Median AVM volume was 2.91 mL (range 0.228-27.313). Median modified radiosurgery-based AVM score was 0.83 (range 0.18-2.96). The most common presenting symptom was intracranial hemorrhage (ICH) (n = 22, 64.7%). Nine patients underwent intervention before LBRS, which included prior embolization or resection. Seven lesions were in eloquent locations, defined as basal ganglia, thalamus, or brainstem. Cerebral angiography was done to confirm obliteration. RESULTS: Median follow-up time was 98 months (range 36-200 months). Twenty-two of the 34 lesions were obliterated (64.7%) with median time to obliteration of 37 months (range 14-79). No deaths occurred during the follow up period; however, two patients experienced ICH after treatment. Three other patients were treated for symptomatic radiation necrosis. CONCLUSIONS: Treatment of intracranial AVM with LBRS in the pediatric population is demonstrated to be safe and effective with long-term follow up. Elsevier 2020-04-13 /pmc/articles/PMC7560570/ /pubmed/33089017 http://dx.doi.org/10.1016/j.adro.2020.03.018 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Scientific Article
Glazener, Ethan M.
Lodin, Kenneth
Miller, Michael J.
Frager, Matthew J.
Rahimian, Javad
Chen, Joseph C.T.
Girvigian, Michael R.
Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery
title Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery
title_full Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery
title_fullStr Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery
title_full_unstemmed Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery
title_short Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery
title_sort pediatric intracranial arteriovenous malformation: long-term outcomes with linear accelerator (linac)-based radiosurgery
topic Scientific Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560570/
https://www.ncbi.nlm.nih.gov/pubmed/33089017
http://dx.doi.org/10.1016/j.adro.2020.03.018
work_keys_str_mv AT glazenerethanm pediatricintracranialarteriovenousmalformationlongtermoutcomeswithlinearacceleratorlinacbasedradiosurgery
AT lodinkenneth pediatricintracranialarteriovenousmalformationlongtermoutcomeswithlinearacceleratorlinacbasedradiosurgery
AT millermichaelj pediatricintracranialarteriovenousmalformationlongtermoutcomeswithlinearacceleratorlinacbasedradiosurgery
AT fragermatthewj pediatricintracranialarteriovenousmalformationlongtermoutcomeswithlinearacceleratorlinacbasedradiosurgery
AT rahimianjavad pediatricintracranialarteriovenousmalformationlongtermoutcomeswithlinearacceleratorlinacbasedradiosurgery
AT chenjosephct pediatricintracranialarteriovenousmalformationlongtermoutcomeswithlinearacceleratorlinacbasedradiosurgery
AT girvigianmichaelr pediatricintracranialarteriovenousmalformationlongtermoutcomeswithlinearacceleratorlinacbasedradiosurgery